CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Moonwalk banks $70m to progress siRNA therapy for obesity

MW101Positive
AI Analysis

Summary

Moonwalk secured $70 million in funding to advance MW101, an siRNA therapy for obesity designed to preserve lean muscle with infrequent dosing.

Importance:5/10
Sentiment:
0.60
siRNAobesityfundingMW101

Read the original article

Published by Pharmaceutical Technology on September 9, 2026 10:44 AM

Read Original